Prostate Ca Updates From ASCO GU 22
Feb 24, 2022•19 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We discuss the evolution of metastatic prostate cancer treatments leading up to last week's publication of ARASENS.
Also, PROPEL and MAGNITUDE hint at an earlier role in therapy of PARP-inhibitors in prostate cancer. Maybe.
For the best experience, listen in Metacast app for iOS or Android